ETF Tuesday
By now, you are probably tired of all the analysis of last week's report pegging third-quarter GDP growth at 1.6%, which is a slowdown from second-quarter growth of 2.6%.
The net result is that the economic Armageddon guys still see the end of days and the no-recession-ever-again crew continues to say that a recession is nowhere near. Regardless of where you stand on the issue, it is worthwhile to think about which segments of the market might weather a slowdown or recession better than others. The usual suspects include consumer staples, health care and dividend paying stocks. WisdomTree offers a fund that includes all of the above, though only in international (non-U.S.) stocks, and it is worth considering: the WisdomTree International Consumer Non-Cyclical Fund (DPN). This ETF is brand new, so all there is to go on are the back-test data. But during the last U.S. recession -- from late 2001 to early 2002 -- the index underlying this fund dramatically outperformed its benchmark index, the MSCI EAFE Index, as shown in the chart below. One thing to point out right off the bat is that this is not your typical staples ETF. Most of the other funds that are dubbed "non-cyclical" or "staples" focus on things like Nilla Wafers and relish. In a twist, DPN throws health care stocks into the mix, a lot of health care. In that regard, DPN partially overlaps with the WisdomTree International Health Care Sector Fund (DBR), but boasts a higher yield. The two funds have five of their respective top 10 stocks in common, and those five health care holdings account for almost 27% of DPN and nearly 40% of DBR: GlaxoSmithKline(GSK), Novartis(NVS), Sanofi-Aventis(SNY), AstraZeneca(AZN) and Roche.| Besting the Index |
![]() |
| Click here for larger image. |
| Source: Morningstar |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,393.45 | 1,310.33 | 2,827.34 | 15.81 |
Oil *
101.78
|
|
DOWN
26.41 |
DOWN
2.99 |
DOWN
10.02 |
DOWN
0.44 |
10 Yr
1.58%
SPDR Gold
151.62
|
|
-0.21%
|
-0.23%
|
-0.35%
|
-2.71%
|
Data delayed 20 minutes |



Connect with TheStreet